Teoxane competitive analysis

Latest publications and patents of Teoxane New

Explore the latest publications and patents granted to Teoxane, showcasing their recent innovations and technological advancements.

Last updated on: Sep 26, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Teoxane

Oct 30, 2024Process For Preparing A Crosslinked GelPatent Maintained As Amended
Jan 26, 2022Injection Devices Comprising A Composition Of Hyaluronic Acid And Mepivacaine HydrochlorideGranted And Under Opposition
Dec 22, 2021Dermal Injectable Sterile CompositionPatent Maintained As Amended
Jun 2, 2021Process Of Preparing A Cross Linked GelGranted And Under Opposition
Nov 6, 2019Process For Preparing HydrogelsOpposition Rejected
Oct 2, 2019Process For Evaluating The Mechanical Performance Of A Filler GelOpposition Rejected
Jun 19, 2019Composition Comprising Hyaluronic Acid And MepivacaineRevoked

Explore Teoxane's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 30, 2024Process For Preparing A Crosslinked Gel1
Jan 26, 2022Injection Devices Comprising A Composition Of Hyaluronic Acid And Mepivacaine Hydrochloride1
Dec 22, 2021Dermal Injectable Sterile Composition1
Jun 2, 2021Process Of Preparing A Cross Linked Gel2
Nov 6, 2019Process For Preparing Hydrogels2
Oct 2, 2019Process For Evaluating The Mechanical Performance Of A Filler Gel1
Jun 19, 2019Composition Comprising Hyaluronic Acid And Mepivacaine3

Latest PTAB cases involving Teoxane

Discover the latest PTAB cases involving Teoxane, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 2, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Teoxane

IPR2017-02002Aug 24, 2017TEOXANEALLERGANInstitution Denied
IPR2017-01906Aug 2, 2017TEOXANEALLERGANInstitution Denied

Peer Comparison New

IP litigation analysis comparing Teoxane with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
TEOXANE - 112 - Defensive
ALLERGAN11281333Balanced
LABORATOIRES VIVACY11 - - - Highly Aggressive
MERZ PHARMA176 - - Highly Aggressive